Sangeeta N. Bhatia, Director at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 21,032 shares at $262.66 ($5.6M) on 2020-10-05, disclosed to the SEC on 2020-10-07.
Open-market sale of $5.6M VRTX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $262.66 | 291 | $76K | 1.4% |
| 2 | $262.66 | 291 | $76K | 1.4% |
| 3 | $263.54 | 594 | $157K | 2.8% |
| 4 | $263.54 | 594 | $157K | 2.8% |
| 5 | $264.60 | 892 | $236K | 4.2% |
| 6 | $264.60 | 892 |
| $236K |
| 4.2% |
| 7 | $265.82 | 1,787 | $475K | 8.5% |
| 8 | $265.82 | 1,787 | $475K | 8.5% |
| 9 | $266.66 | 2,070 | $552K | 9.8% |
| 10 | $266.66 | 2,070 | $552K | 9.8% |
| 11 | $267.92 | 2,670 | $715K | 12.7% |
| 12 | $267.92 | 2,670 | $715K | 12.7% |
| 13 | $268.61 | 2,212 | $594K | 10.6% |
| 14 | $268.61 | 2,212 | $594K | 10.6% |
| Total | $266.79 avg | 21,032 | $5.6M | 100% |
| Filing → |
| VRTX | SELL | 2025-08-29 | $206K | — | Filing → |
| VRTX | SELL | 2025-05-05 | $202K | — | Filing → |
| VRTX | SELL | 2024-09-04 | $323K | — | Filing → |